Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial of HRS-3095 in Healthy Volunteers
Sponsor: Atridia Pty Ltd.
Summary
The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants
Official title: A Phase 1, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of HRS-3095 in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2026-07-30
Completion Date
2026-10-15
Last Updated
2026-07-07
Healthy Volunteers
Yes
Conditions
Interventions
HRS-3095
Single dose HRS-3095 /placebo given orally - Dose level 1
HRS-3095
Single dose HRS-3095 /placebo given orally - Dose level 2
HRS-3095
Single dose HRS-3095 /placebo given orally - Dose level 3
Locations (1)
Veritus Research
Bayswater, Victoria, Australia